These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3903984

  • 1. [The prognostic significance of quantitative HBsAG determination in acute hepatitis B].
    Joller-Jemelka HI, Pfister HF, Grob PJ.
    Schweiz Med Wochenschr; 1985 Sep 14; 115(37):1249-56. PubMed ID: 3903984
    [Abstract] [Full Text] [Related]

  • 2. [Behavior and clinical significance of the eAg/ anti-e system in carriers of HBsAg].
    Pastore G, Dentico P, Fera G, Angarano G, Schiraldi O.
    Boll Ist Sieroter Milan; 1977 Sep 14; 56(4):333-8. PubMed ID: 911461
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C, Koç H, Karayalcin S, Akyol G, Gürman G, Ilhan O, Akan H, Ozcan M, Arslan O, Konuk N, Uysal A, Beksaç M.
    Bone Marrow Transplant; 1997 Aug 14; 20(4):289-96. PubMed ID: 9285543
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B surface antigen and immunoglobulin M complexes in chronic carriers and patients with acute and chronic liver diseases.
    Ayoola EA, Olubuyide I.
    Afr J Med Med Sci; 1989 Mar 14; 18(1):21-4. PubMed ID: 2545079
    [Abstract] [Full Text] [Related]

  • 5. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B, Nazarewicz-de Mezer T, Krawczyński K.
    Przegl Epidemiol; 1984 Mar 14; 38(3):249-56. PubMed ID: 6528039
    [No Abstract] [Full Text] [Related]

  • 6. Role of delta infection in the progression to chronicity of acute HBsAg positive hepatitis.
    Caporaso N, del Vecchio-Blanco C, Servillo F, Suozzo R, Pignalosa G, Manzillo G, Maio G, Izzo CM, Coltorti M.
    Gastroenterol Clin Biol; 1984 Mar 14; 8(8-9):646-50. PubMed ID: 6489684
    [Abstract] [Full Text] [Related]

  • 7. Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection.
    Paul S, Tabassum S, Islam MN.
    Bangladesh Med Res Counc Bull; 2004 Aug 14; 30(2):71-7. PubMed ID: 15813485
    [Abstract] [Full Text] [Related]

  • 8. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R, Dentico P, Santantonio T, Frappampina V, Spinelli A, Amato M, Pastore G.
    Boll Soc Ital Biol Sper; 1980 Oct 30; 56(20):2076-82. PubMed ID: 7459119
    [Abstract] [Full Text] [Related]

  • 9. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
    Farci P, Smedile A, Lavarini C, Piantino P, Crivelli O, Caporaso N, Toti M, Bonino F, Rizzetto M.
    Gastroenterology; 1983 Sep 30; 85(3):669-73. PubMed ID: 6873613
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A, Dentico P, Zanetti A, Sagnelli E, Nordenfelt E, Actis GC, Rizzetto M.
    Gastroenterology; 1981 Dec 30; 81(6):992-7. PubMed ID: 7286594
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N, Novák E.
    Clin Exp Immunol; 1981 Feb 30; 43(2):246-53. PubMed ID: 7273479
    [Abstract] [Full Text] [Related]

  • 17. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H, Japanese Red Cross NAT Screening Research Group.
    Transfusion; 2007 Jul 30; 47(7):1162-71. PubMed ID: 17581150
    [Abstract] [Full Text] [Related]

  • 18. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM, Ng WC, Kang JY, Yap I, Seet BL, Teo J, Smith R, Guan R.
    Singapore Med J; 1996 Apr 30; 37(2):150-2. PubMed ID: 8942251
    [Abstract] [Full Text] [Related]

  • 19. [Follow-up of nitric oxide levels in acute hepatitis B patients].
    Bulut Y, Ozuğurlu AF.
    Mikrobiyol Bul; 2002 Apr 30; 36(3-4):283-9. PubMed ID: 12838662
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.